LivaNova PLC - Ordinary Shares (LIVN) News
Filter LIVN News Items
LIVN News Results
|Loading, please wait...|
LIVN News Highlights
- 500 - Internal server error
- Over the past 15 days, the trend for LIVN's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about LIVN are CSL and HAE.
Latest LIVN News From Around the Web
Below are the latest news stories about LivaNova PLC that investors may wish to consider to help them evaluate LIVN as an investment opportunity.
Helius Medical Technologies, Inc. Appoints Frederick Fantazzia as Vice President of Sales & Marketing, North America
NEWTOWN, Pa., June 02, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the appointment of Frederick Fantazzia to the position of Vice President of Sales & Marketing, North America, effective June 1, 2021. “Fred is a dynamic leader with 16 years of sales and marketing experience in the field of neuromodulation, and a specific focus on developing the market for new
LivaNova PLC today announced it has successfully completed the initial closing of the divestiture of its heart valve business to Gyrus Capital.
Photo by Elkhophoto/iStock via Getty ImagesInvestment Summary Back in April, Haemonetics Corp (HAE) revealed their supply agreement with CSL Plasma, covering the use of PCS2, will not continue for the from 06/30/2022. As of FY2020, total revenues were exposed ~12% to this high-margin agreement, therefore, ~12% of HAE's top line...
LivaNova PLC ( NASDAQ:LIVN ) is possibly approaching a major achievement in its business, so we would like to shine...
LivaNova and Verily Announce First Patient Enrolled in Study to Evaluate Treatment Effectiveness for Patients Living with Depression
LivaNova and Verily today announced that the first patient has been enrolled in their collaborative UNCOVER study for difficult-to-treat depression.
LivaNova Receives FDA 510(k) Clearance for B-Capta, the New In-Line, Blood-Gas Monitoring System Integrated Into the S5 Heart-Lung Machine
LivaNova today announced it received U.S. FDA 510(k) clearance for B-Capta, the new in-line, blood-gas monitoring system integrated into the S5 HLM.
Epilepsy Market Undertake Strapping Growth By 2027 With LivaNova PLC, GlaxoSmithKline PLC, Eisai Co. Ltd., Pfizer Inc., Medtronic PLC, GW Pharmaceuticals PLC, Novartis AG, Johnson & Johnson Services Inc., Abbott Laboratories, Becton Dickinson and Company
Epilepsy research report provides deep insights into the Global Epilepsy market revenue, parent market trends, macro-economic indicators, and governing factors, along with market attractiveness per market segment. The report provides an overview of the growth rate of the Epilepsy during
Cardiopulmonary Autotransfusion Systems Market is Thriving Worldwide 2021-2025 | Leading Players - Medtronic, Terumo, Advancis Surgical, Fresenius Kabi, Haemonetics, LivaNova, Stryker
BusinessIndustryReports has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Cardiopulmonary Autotransfusion Systems Market” Research Report 2021 provides an in-depth analysis of the Cardiopulmonary Autotransfusion Systems with the forecast of market size and
Active Implantable Medical Devices Market 2021 - 2027 Size, Industry Share, Growth, COVID-19 Analysis, Top Key Players : Boston Scientific Corporation, Biotronik, LivaNova PLC, Globus Medical, Inc., NuVasive
Rise in prevalence of chronic diseases, supportive initiatives from medical health insurance companies for critical issues, and increase in awareness regarding different types of implants drive the growth of the global medical implant market. However, high cost of treatment and
Autotransfusion Device Market With Leading Players like Medtronic, Fresenius SE & Co. KGaA, Teleflex Incorporated BD, Zimmer Biomet, BraileBiomedica, Haemonetics Corporation, SARSTEDT AG and Co. KG, LivaNova PLC, Redax S.p.A.
An off-the-shelf report on Autotransfusion Device Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as